GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Repligen Corp (FRA:RGN) » Definitions » E10

Repligen (FRA:RGN) E10 : €0.94 (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Repligen E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Repligen's adjusted earnings per share data for the three months ended in Sep. 2024 was €-0.009. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.94 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Repligen's average E10 Growth Rate was -4.40% per year. During the past 3 years, the average E10 Growth Rate was 31.60% per year. During the past 5 years, the average E10 Growth Rate was 34.80% per year. During the past 10 years, the average E10 Growth Rate was 16.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Repligen was 180.20% per year. The lowest was -3.30% per year. And the median was 17.80% per year.

As of today (2025-01-18), Repligen's current stock price is €157.00. Repligen's E10 for the quarter that ended in Sep. 2024 was €0.94. Repligen's Shiller PE Ratio of today is 167.02.

During the past 13 years, the highest Shiller PE Ratio of Repligen was 538.77. The lowest was 64.12. And the median was 160.41.


Repligen E10 Historical Data

The historical data trend for Repligen's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Repligen E10 Chart

Repligen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.38 0.63 0.98 0.99

Repligen Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.07 0.99 1.01 1.00 0.94

Competitive Comparison of Repligen's E10

For the Medical Instruments & Supplies subindustry, Repligen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Repligen's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Repligen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Repligen's Shiller PE Ratio falls into.



Repligen E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Repligen's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.009/133.0289*133.0289
=-0.009

Current CPI (Sep. 2024) = 133.0289.

Repligen Quarterly Data

per share eps CPI Adj_EPS
201412 -0.008 99.070 -0.011
201503 0.083 99.621 0.111
201506 0.098 100.684 0.129
201509 0.071 100.392 0.094
201512 0.009 99.792 0.012
201603 0.045 100.470 0.060
201606 0.098 101.688 0.128
201609 0.027 101.861 0.035
201612 0.142 101.863 0.185
201703 0.084 102.862 0.109
201706 0.214 103.349 0.275
201709 0.092 104.136 0.118
201712 0.228 104.011 0.292
201803 0.065 105.290 0.082
201806 0.051 106.317 0.064
201809 0.086 106.507 0.107
201812 0.105 105.998 0.132
201903 0.150 107.251 0.186
201906 0.150 108.070 0.185
201909 0.027 108.329 0.033
201912 0.063 108.420 0.077
202003 0.163 108.902 0.199
202006 0.266 108.767 0.325
202009 0.229 109.815 0.277
202012 0.296 109.897 0.358
202103 0.437 111.754 0.520
202106 0.531 114.631 0.616
202109 0.493 115.734 0.567
202112 0.443 117.630 0.501
202203 0.735 121.301 0.806
202206 0.832 125.017 0.885
202209 0.717 125.227 0.762
202212 0.802 125.222 0.852
202303 0.252 127.348 0.263
202306 0.323 128.729 0.334
202309 0.281 129.860 0.288
202312 -0.422 129.419 -0.434
202403 0.055 131.776 0.056
202406 0.093 132.554 0.093
202409 -0.009 133.029 -0.009

Add all the adjusted EPS together and divide 10 will get our e10.


Repligen  (FRA:RGN) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Repligen's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=157.00/0.94
=167.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Repligen was 538.77. The lowest was 64.12. And the median was 160.41.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Repligen E10 Related Terms

Thank you for viewing the detailed overview of Repligen's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Repligen Business Description

Traded in Other Exchanges
Address
41 Seyon Street, Building 1, Suite 100, Waltham, MA, USA, 02453
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Repligen Headlines

No Headlines